Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

J Bowes, AJ Brown, J Hamon, W Jarolimek… - Nature reviews Drug …, 2012 - nature.com
In vitro pharmacological profiling is increasingly being used earlier in the drug discovery
process to identify undesirable off-target activity profiles that could hinder or halt the …
被引用次数：734 相关文章

[引用][C] Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

J Bowes, AJ Brown, J Hamon, W Jarolimek… - Nature Reviews Drug …, 2012 - cir.nii.ac.jp
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

J Bowes, AJ Brown, J Hamon, W Jarolimek… - Nature Reviews. Drug …, 2012 - hero.epa.gov
In vitro pharmacological profiling is increasingly being used earlier in the drug discovery
process to identify undesirable off-target activity profiles that could hinder or halt the …

Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

J Bowes, AJ Brown, J Hamon, W Jarolimek… - Nature Reviews Drug …, 2012 - go.gale.com
In vitro pharmacological profiling is increasingly being used earlier in the drug discovery
process to identify undesirable off-target activity profiles that could hinder or halt the …
[PDF] semanticscholar.org

[PDF][PDF] Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

J Bowes, GS Assessment - pdfs.semanticscholar.org
• Most major Pharmaceutical companies do in vitro profiling during Discovery-AZ, Novartis,
Pfizer and GSK all utilise profiling panels not to just select and design in vivo safety …

Reducing safety-related drug attrition: The use of in vitro pharmacological profiling

J Bowes, AJ Brown, J Hamon… - Nature Reviews Drug …, 2012 - oak.novartis.com
In vitro pharmacological profiling is increasingly being used earlier in the drug discovery
process to identify undesirable off-target activity profiles that could hinder or halt the …

Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

J Bowes, AJ Brown, J Hamon… - Nature reviews …, 2012 - pubmed.ncbi.nlm.nih.gov
In vitro pharmacological profiling is increasingly being used earlier in the drug discovery
process to identify undesirable off-target activity profiles that could hinder or halt the …

Reducing safety-related drug attrition: the use of in vitro pharmacological profiling.

J Bowes, AJ Brown, J Hamon… - Nature Reviews …, 2012 - search.ebscohost.com
In vitro pharmacological profiling is increasingly being used earlier in the drug discovery
process to identify undesirable off-target activity profiles that could hinder or halt the …
[PDF] researchgate.net

[PDF][PDF] Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

J Bowes, AJ Brown, J Hamon… - NATURE REVIEWS …, 2012 - researchgate.net
In vitro pharmacological profiling is increasingly being used earlier in the drug discovery
process to identify undesirable off-target activity profiles that could hinder or halt the …

Reducing safety-related drug attrition: The use of in vitro pharmacological profiling

J Bowes, AJ Brown, J Hamon… - Nature Reviews Drug …, 2012 - oak.novartis.com
In vitro pharmacological profiling is increasingly being used earlier in the drug discovery
process to identify undesirable off-target activity profiles that could hinder or halt the …